carisoprodol has been researched along with Adult Neuronal Ceroid Lipofuscinosis in 1 studies
Carisoprodol: A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1202)
carisoprodol : A carbamate ester that is the mono-N-isopropyl derivative of meprobamate (which is a significant metabolite). Carisoprodol interrupts neuronal communication within the reticular formation and spinal cord, resulting in sedation and alteration in pain perception. It is used as a muscle relaxant in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benitez, BA | 1 |
| Sands, MS | 1 |
1 other study available for carisoprodol and Adult Neuronal Ceroid Lipofuscinosis
| Article | Year |
|---|---|
Primary fibroblasts from CSPĪ± mutation carriers recapitulate hallmarks of the adult onset neuronal ceroid lipofuscinosis.
Topics: Adult; Age of Onset; Carisoprodol; Cells, Cultured; Fibroblasts; Heterozygote; HSP40 Heat-Shock Prot | 2017 |